D R Taylor

Author PubWeight™ 117.24‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 1990 9.93
2 Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature 1990 3.80
3 The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Respir Crit Care Med 2001 3.35
4 Making the diagnosis of asthma. BMJ 1997 3.01
5 Autophosphorylation in the activation loop is required for full kinase activity in vivo of human and yeast eukaryotic initiation factor 2alpha kinases PKR and GCN2. Mol Cell Biol 1998 2.39
6 Hepatitis C virus RNA polymerase and NS5A complex with a SNARE-like protein. Virology 1999 2.33
7 Immunoglobulin switch transcript production in vivo related to the site and time of antigen-specific B cell activation. J Exp Med 1996 2.18
8 Effects of cannabis on lung function: a population-based cohort study. Eur Respir J 2009 2.16
9 T helper 1 (Th1) and Th2 characteristics start to develop during T cell priming and are associated with an immediate ability to induce immunoglobulin class switching. J Exp Med 1998 1.91
10 Intrinsic constraint on plasmablast growth and extrinsic limits of plasma cell survival. J Exp Med 2000 1.87
11 Functional characterization of the RNA-binding domain and motif of the double-stranded RNA-dependent protein kinase DAI (PKR). J Mol Biol 1995 1.64
12 The beta 2-agonist controversy. Observations, explanations and relationship to asthma epidemiology. Drug Saf 1994 1.60
13 Use of phentolamine in acute myocardial infarction associated with hypertension and left ventricular failure. Circulation 1973 1.57
14 Predicting steroid responsiveness in patients with asthma using exhaled breath profiling. Clin Exp Allergy 2013 1.44
15 Local population structure and sex ratio: evolution in gynodioecious plants. Am Nat 1997 1.44
16 Water-saline controversy or deficient regional anesthesia training? Anesth Analg 1994 1.39
17 Genomic admixture increases fitness during a biological invasion. J Evol Biol 2010 1.37
18 Intravenous nitroglycerin in acute myocardial infarction. Circulation 1975 1.32
19 The efficacy of orally administered theophylline, inhaled salbutamol, and a combination of the two as chronic therapy in the management of chronic bronchitis with reversible air-flow obstruction. Am Rev Respir Dis 1985 1.31
20 Investigation of diurnal changes in the disposition of theophylline. Br J Clin Pharmacol 1983 1.29
21 The effect of adiposity measured by dual-energy X-ray absorptiometry on lung function. Eur Respir J 2008 1.28
22 Polymorphism of the beta2-adrenoceptor and the response to long-term beta2-agonist therapy in asthma. Eur Respir J 1998 1.16
23 Circadian variation in plasma theophylline concentrations during maintenance therapy with a sustained-release preparation in patients with obstructive airways disease. Br J Clin Pharmacol 1984 1.15
24 Exhaled NO and assessment of anti-inflammatory effects of inhaled steroid: dose-response relationship. Eur Respir J 2002 1.14
25 Thiazolinone analogues of indolmycin with antiviral and antibacterial activity. J Med Chem 1978 1.10
26 Hemodynamic and prognostic findings in patients with transmural and nontransmural infarction. Circulation 1975 1.09
27 Right ventricular dysfunction detected by gated scintiphotography in patients with acute inferior myocardial infarction. Circulation 1975 1.08
28 Sex ratio variance and the maintenance of environmental sex determination. J Evol Biol 2007 1.05
29 Relationship between socioeconomic status and asthma: a longitudinal cohort study. Thorax 2004 1.05
30 Pulmonary artery sarcoma mimicking pulmonary embolism. Chest 1993 1.02
31 Bronchodilator tolerance: the impact of increasing bronchoconstriction. Eur Respir J 2003 1.01
32 Tolerance to beta-agonists during acute bronchoconstriction. Eur Respir J 1999 1.01
33 The role of furosemide in the treatment of left ventricular dysfunction associated with acute myocardial infarction. Circulation 1973 0.99
34 Myocardial-infarct extension detected by precordial ST-segment mapping. N Engl J Med 1974 0.98
35 Bronchodilator treatment in asthma. BMJ 1993 0.98
36 Acral lentiginous melanoma. Cutis 1980 0.98
37 Plasma theophylline concentrations in patients with chronic obstructive airways disease after administration of a new sustained release theophylline formulation. Br J Clin Pharmacol 1982 0.94
38 Craniofacial form and obstructive sleep apnea in Polynesian and Caucasian men. Sleep 2000 0.91
39 A case report of obstructive sleep apnea in a patient with bipolar affective disorder. Can J Psychiatry 1985 0.91
40 Prediction of optimum oral theophylline dose in patients with obstructive airways disease. Br J Clin Pharmacol 1983 0.90
41 Patient compliance with oral theophylline therapy. Br J Clin Pharmacol 1984 0.90
42 A case of melorheostosis with associated linear cutaneous vascular malformation. Clin Exp Dermatol 1981 0.90
43 Hydrated sodium calcium aluminosilicate: a high affinity sorbent for aflatoxin. Poult Sci 1988 0.90
44 Retrospective multicentre study of methicillin-resistant Staphylococcus aureus infections in 115 horses. Equine Vet J 2009 0.89
45 Gastric pneumatosis following cardiac surgery. Eur J Pediatr 2000 0.88
46 Low seroprevalence of Helicobacter pylori antibodies in historical sera of patients with Crohn's disease. Scand J Gastroenterol 1997 0.87
47 Bronchodilator treatment in asthma. Increase in deaths during salmeterol treatment unexplained. BMJ 1993 0.87
48 Treatment outcome of obstructive sleep apnea. Physiological and neuropsychological concomitants. J Nerv Ment Dis 1987 0.87
49 Reversing acute bronchoconstriction in asthma: the effect of bronchodilator tolerance after treatment with formoterol. Eur Respir J 2001 0.86
50 Bronchodilators and bronchial hyperresponsiveness. Thorax 1994 0.86
51 Role of sublingual nitroglycerin in patients with acute myocardial infarction. Br Heart J 1975 0.86
52 Pattern-recognition arm prosthesis: a historical perspective-a final report. Bull Prosthet Res 1978 0.85
53 Characterization of microbial communities using randomly amplified polymorphic DNA (RAPD). J Microbiol Methods 1999 0.85
54 Serum beta-aminopropionaldehyde: identification and origin. Clin Chim Acta 1970 0.84
55 Oxidative transformations of polycyclic aromatic hydrocarbons adsorbed on coal fly ash. Science 1980 0.84
56 Long-acting beta-agonist treatment in patients with persistent asthma already receiving inhaled corticosteroids. BioDrugs 2001 0.84
57 Care plans for acutely deteriorating COPD: a randomized controlled trial. Chron Respir Dis 2004 0.84
58 Effects of intravenous nitroglycerin on left ventricular function and ST segment changes in acute myocardial infarction. Br Heart J 1976 0.84
59 Chronic interstitial lung disease in a welder of galvanized steel. Occup Med (Lond) 1994 0.83
60 Exhaled nitric oxide and pulmonary artery pressures during graded ascent to high altitude. Respir Physiol Neurobiol 2011 0.82
61 Hepatitis C virus and interferon resistance: it's more than just PKR. Hepatology 2001 0.81
62 Increased inhaled bronchodilator vs increased inhaled corticosteroid in the control of moderate asthma. Chest 1992 0.81
63 Identification of endogenous gibberellins in strawberry, including the novel gibberellins GA123, GA124 and GA125. Phytochemistry 2000 0.80
64 Comprehensive management of non-insulin-dependent diabetes mellitus. A diabetes clinic revisited. S Afr Med J 1996 0.80
65 Bronchodilator tolerance and rebound bronchoconstriction during regular inhaled beta-agonist treatment. Respir Med 2000 0.80
66 Changes in blood coagulability in dogs following flash burns. J Trauma 1965 0.79
67 Effects of inhaled beta agonist and corticosteroid treatment on nuclear transcription factors in bronchial mucosa in asthma. Thorax 1999 0.79
68 Randomised trial of an inhaled beta2 agonist, inhaled corticosteroid and their combination in the treatment of asthma. Thorax 1999 0.79
69 Pseudomonas aeruginosa transmission is infrequent in New Zealand cystic fibrosis clinics. Eur Respir J 2008 0.78
70 Pilomatrix carcinoma. J Surg Oncol 1986 0.78
71 Involvement of dopamine receptor subtypes in dopaminergic modulation of aldosterone secretion in rats. Life Sci 1987 0.78
72 Bronchoprotective and bronchodilator effects of single doses of (S)-salbutamol, (R)-salbutamol and racemic salbutamol in patients with bronchial asthma. Eur J Clin Pharmacol 1999 0.78
73 Introns resolve the conflict between base order-dependent stem-loop potential and the encoding of RNA or protein: further evidence from overlapping genes. Gene 2001 0.77
74 Growth inhibition of Escherichia coli by some basic proteins prepared from the same strain. Nature 1965 0.77
75 An eye to the future: exhaled nitric oxide as a predictor of clinical outcomes in asthma. Eur Respir J 2010 0.77
76 Effects of intraaortic balloon counterpulsation on regional coronary blood flow in experimental myocardial infarction. Am J Cardiol 1974 0.77
77 Cardiovascular and renal actions of calcium channel blocker chemical subgroups: a search for renal specificity. J Pharm Pharmacol 1988 0.77
78 Activation of human neutrophils by calcium carbonate polymorphs. Dig Dis Sci 1997 0.77
79 Correlation of anthothecol and hirtin. Experientia 1977 0.77
80 Excessive use of inhaled salbutamol: the potential benefits of dose-reduction. A case report. N Z Med J 1999 0.76
81 Effect of bopindolol on renin secretion and renal excretory function in rats. J Cardiovasc Pharmacol 1989 0.76
82 D- and L-lactate dehydrogenases in Escherichia coli. Biochim Biophys Acta 1966 0.76
83 Clostridium difficile diarrhea in patients with AIDS versus non-AIDS controls. Methods of treatment and clinical response to treatment. J Clin Gastroenterol 1993 0.76
84 Fluctuation analysis of lung function as a predictor of long-term response to beta2-agonists. Eur Respir J 2008 0.76
85 Chronic obstructive pulmonary disease. No longer any justification for therapeutic nihilism. BMJ 1998 0.76
86 Distribution of hepatitis C virus in circulating blood components from blood donors. Vox Sang 2012 0.76
87 Asthma control. Lancet 1994 0.75
88 Re: Asthma prevention: breast is best? J Paediatr Child Health 2005 0.75
89 Exhaled nitric oxide and COPD. Eur Respir J 2010 0.75
90 Asthma and beta agonists. N Z Med J 1991 0.75
91 Regular beta-agonist therapy--the quality of the evidence. Eur Respir J 1992 0.75
92 Asthma morbidity and mortality in New Zealand. Thorax 1995 0.75
93 Response to "Breastfeeding, asthma, and atopic disease: an epidemiological review of the literature" by Oddy and Peat. J Hum Lact 2004 0.75
94 Regular versus as-needed inhaled salbutamol in asthma control. Lancet 1994 0.75
95 Regular inhaled beta-adrenergic agonists in the treatment of bronchial asthma. Am Rev Respir Dis 1992 0.75
96 Dermatology-epitomes of progress: acral lentiginous melanoma. West J Med 1981 0.75
97 Nodules at infection sites. Br Med J (Clin Res Ed) 1981 0.75
98 Defining the role of exhaled nitric oxide measurements in COPD. Respirology 2010 0.75
99 The opiate addiction test: a clinical evaluation of a quick test for physical dependence on opiate drugs. Br J Clin Pharmacol 1995 0.75
100 Regularly inhaled beta-agonists in stable asthma. J Allergy Clin Immunol 1995 0.75
101 Sex differences in hypokalaemic and electrocardiographic effects of inhaled terbutaline. Thorax 1993 0.75
102 Prediction of maintenance oral theophylline dosage using single oral doses in patients with obstructive airways disease. Br J Clin Pharmacol 1983 0.75
103 Beta2-agonist enantiomers: is there a glitch with the chiral switch? Eur Respir J 1999 0.75
104 Amiodarone pulmonary toxicity: its radiological features. Australas Radiol 1993 0.75
105 Engineering principles in the control of external power by myoelectric signals. Arch Phys Med Rehabil 1968 0.75
106 Bowenoid papulosis: a review. Cutis 1981 0.75
107 Steroid-sparing agents in the treatment of asthma. Med J Aust 1992 0.75
108 Isomer specific syntheses of chlorinated catechols and guaiacols relevant to pulp bleaching. Chemosphere 2001 0.75
109 The efficacy of inhaled corticosteroids in the management of non asthmatic chronic airflow obstruction. N Z Med J 1997 0.75
110 Cardiovascular and renal actions of AHR-16303B, an antagonist of 5-HT2 receptors and calcium channels, in hypertensive and normotensive rats. J Cardiovasc Pharmacol 1991 0.75
111 The role of phospholipid metabolism in bromobenzene- and carbon tetrachloride-dependent hepatocyte injury. Toxicol Appl Pharmacol 1984 0.75
112 A new index of prognostic severity for chronic asthma. Chest 1997 0.75
113 Hemodynamic effects of plasma volume expansion and prognostic implications in acute myocardial infarction. Circulation 1974 0.75
114 Laboratory for kinesiologic analysis. Bull Prosthet Res 1970 0.75
115 Intensified insulin therapy in insulin-dependent diabetics using a convenience syringe. S Afr Med J 1989 0.75
116 Chronic mucocutaneous candidiasis, pernicious anaemia and IgA deficiency. Br J Dermatol 1979 0.75
117 The relationship between the development and progression of microalbuminuria and arterial blood pressure in type 1 (insulin-dependent) diabetes mellitus. Diabetes Res Clin Pract 1992 0.75
118 Holter electrocardiographic recording: Part 2, Current indications and applications. Md State Med J 1977 0.75
119 Protective effect of p-chlorophenylalanine in glycerol-induced acute renal failure in rats. Clin Sci (Lond) 1989 0.75
120 Serum insulin levels in diabetics after subcutaneous administration of Rapitard insulin. Med J Aust 1976 0.75
121 Holter recording: Part 1, History and current status. Md State Med J 1977 0.75
122 Actraphane and Lentard insulin for once daily insulin supplementation. S Afr Med J 1988 0.75
123 A solid-state instrument for measuring dynamic changes in the pupil of the human eye. J Biomed Eng 1984 0.75
124 Increased ratio of helper to suppressor T cells in alopecia areata. Br J Dermatol 1984 0.75
125 Derman cryptococcosis in a cat. Mod Vet Pract 1978 0.75
126 Multicentric reticulohistiocytosis. Arch Dermatol 1977 0.75
127 Piebaldism. Br J Dermatol 1976 0.75
128 The effect of regular salbutamol on lung function and bronchial hyperresponsiveness in normal subjects and nonasthmatic atopic subjects with allergic rhinitis. Chest 1997 0.75
129 Suppression of ovarian function by Microgynon 30 in day 1 and day 5 "starters". Contraception 1986 0.75